Abstract

Introduction Since the introduction of antibiotics to the medical armamentarium little attention has been given to the value of bacterial vaccines for the prevention and treatment of the common cold. The use of antibiotics has greatly reduced the serious complications of upper respiratory infections. We see very few serious complications such as mastoiditis, meningitis, extensive sinus infections, etc. However, it is our feeling that there has been a definite increase in the frequency of upper respiratory infections. A patient develops an acute cold, with secondary bacterial invaders producing the disagreeable symptoms that go with an acute cold. He or she is given intensive antibiotic or sulfonamide therapy. The patient recovers from this upper respiratory infection only to develop another within one to three weeks. This is repeated over and over again until the patient seems to have a continuous upper respiratory problem. It is our feeling that the use of

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call